HKeyBio is building HKEY-AI4AI-Atlas™ 1.0, its AI-Assisted Autoimmune Model Data Atlas. The internal capability-building initiative uses AI-assisted dataset curation, standardization and retrieval to ...
HKeyBio is building HKEY-AI4AI-Atlastm 1.0, its AI-Assisted Autoimmune Model Data Atlas. The internal capability-building initiative uses AI-assisted dataset curation, standardization and retrieval to ...
Morning Overview on MSN
The FDA cleared a once-a-week Alzheimer’s shot that patients can give themselves at home
People living with early Alzheimer’s disease can now begin treatment with Leqembi without setting foot in an infusion center.
Syntis Bio, Inc. a clinical-stage biopharmaceutical company advancing novel oral therapeutics that uniquely leverage the ...
The treatment landscape for C3G has historically depended on the off-label use of multiple prescription therapies, ...
Below is Alston & Bird’s Health Care Week in Review, which provides a synopsis of the latest news in health care regulations, notices, and ...
Antimicrobial resistance (AMR) in mycobacterial infections has emerged as one of the most pressing challenges to global ...
Over the past few decades, digital twin technology has evolved into a highly versatile tool. Initially used in the aerospace industry, digital twins can now form the dynamic backbone of systems in ...
Equitable access to newer antibiotics relies on commitments to strengthening health systems’ infrastructure and facilitating ...
Nicotinamide adenine dinucleotide (NAD) and its reduced form (NADH) therapy are dietary supplements that are promoted widely ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results